BACKGROUND AND OBJECTIVES: The effect of mycophenolate mofetil (MMF) on T cell function has not been evaluated in patients undergoing kidney transplantation. The aim of this study was to assess the effect of 1g of MMF on T cell function, that is, intralymphocyte cytokine expression, T cell activation (CD25 and CD71), and T cell proliferation, as well as inosine monophosphate dehydrogenase (IMPDH) activity, to better understand the relationship between pharmacokinetic and pharmacodynamic markers in patients receiving the first dose of MMF before kidney transplantation. PATIENTS: Twenty-four patients undergoing a kidney transplantation from a living donor were enrolled in this study. RESULTS: Compared with baseline (before MMF intake), T cell proliferation (93%), IMPDH activity (74%), CD25 (46%), and CD71 (50%) expression significantly decreased during the first hour after MMF intake, in parallel to the rise in MPA concentration. Thereafter, all pharmacodynamic markers, except IMPDH activity, returned back to baseline level. There was a complex inverse relationship between pharmacokinetic and pharmacodynamic markers. The inhibition of T cell proliferation was highly correlated to IMPDH activity, but also to T cell activation markers. CONCLUSION: The administration of MMF to patients is associated not only with a dramatic decrease in both T cell proliferation and IMPDH activity, but also with in a decrease in CD25 and CD71 expression.
BACKGROUND AND OBJECTIVES: The effect of mycophenolate mofetil (MMF) on T cell function has not been evaluated in patients undergoing kidney transplantation. The aim of this study was to assess the effect of 1g of MMF on T cell function, that is, intralymphocyte cytokine expression, T cell activation (CD25 and CD71), and T cell proliferation, as well as inosine monophosphate dehydrogenase (IMPDH) activity, to better understand the relationship between pharmacokinetic and pharmacodynamic markers in patients receiving the first dose of MMF before kidney transplantation. PATIENTS: Twenty-four patients undergoing a kidney transplantation from a living donor were enrolled in this study. RESULTS: Compared with baseline (before MMF intake), T cell proliferation (93%), IMPDH activity (74%), CD25 (46%), and CD71 (50%) expression significantly decreased during the first hour after MMF intake, in parallel to the rise in MPA concentration. Thereafter, all pharmacodynamic markers, except IMPDH activity, returned back to baseline level. There was a complex inverse relationship between pharmacokinetic and pharmacodynamic markers. The inhibition of T cell proliferation was highly correlated to IMPDH activity, but also to T cell activation markers. CONCLUSION: The administration of MMF to patients is associated not only with a dramatic decrease in both T cell proliferation and IMPDH activity, but also with in a decrease in CD25 and CD71 expression.
Authors: P Glander; K P Braun; P Hambach; S Bauer; I Mai; I Roots; J Waiser; L Fritsche; H H Neumayer; K Budde Journal: Clin Biochem Date: 2001-10 Impact factor: 3.281
Authors: K Budde; P Glander; K P Braun; T Böhler; J Waiser; L Fritsche; I Mai; H Neumayer Journal: Transplant Proc Date: 2001 Nov-Dec Impact factor: 1.066
Authors: K Budde; K-P Braun; P Glander; T Böhler; P Hambach; L Fritsche; J Waiser; I Mai; H-H Neumayer Journal: Transplant Proc Date: 2002-08 Impact factor: 1.066
Authors: Y Qiu; L D Fairbanks; K Rückermann; C M Hawrlowicz; D F Richards; B Kirschbaum; H A Simmonds Journal: Transplantation Date: 2000-03-15 Impact factor: 4.939
Authors: Markus J Barten; Teun van Gelder; Jan F Gummert; Katrin Boeke; Randi Shorthouse; Margaret E Billingham; Randall E Morris Journal: Am J Transplant Date: 2002-09 Impact factor: 8.086
Authors: Markus J Barten; Teun van Gelder; Jan F Gummert; Randi Shorthouse; Randall E Morris Journal: Transpl Immunol Date: 2002-06 Impact factor: 1.708
Authors: M Grobman; D M Boothe; H Rindt; B G Williamson; M L Katz; J R Coates; C R Reinero Journal: J Vet Pharmacol Ther Date: 2017-06-25 Impact factor: 1.786
Authors: Charles D Varnell; Tsuyoshi Fukuda; Cassie L Kirby; Lisa J Martin; Barry L Warshaw; Hiren P Patel; Deepa H Chand; Gina-Marie Barletta; Scott K Van Why; Rene G VanDeVoorde; Donald J Weaver; Amy Wilson; Priya S Verghese; Alexander A Vinks; Larry A Greenbaum; Jens Goebel; David K Hooper Journal: Pediatr Transplant Date: 2017-09-04